Units Used / Wasted
Eylea
2
HPI
History of Present Illness
Type of RVO approved for use with Eylea
RVO +macular edema
Bloodwork, generalized markers for inflammation
ESR/CRP
IVE OD CRVO with ME Q8w. Decreased edema on OCT. Patient states vision improving. Last exam charged 6 months ago. What exam/modifiers?
No exam
sub-Tenon's Kenalog
4
PVR
Proliferative Vitreoretinopathy
Dose of Lucentis for diabetic retinopathy
0.3
Sexually Transmitted Infection, can be confirmed with RPR.
Syphilis
IVE OD CRVO with ME Q8w. Patient complains of new flashes and floaters left eye x5 days. New PVD OS without tears or detachments. Patient reassured. Treat as planned and recheck in 8 weeks, sooner with changes. Tear and detachment warning symptoms reviewed. What exam/modifiers?
92014 [25]
intravitreal Kenalog
1 / 3
KP
Keratic Precipitates
High cost med you can use for myopic CNV
Lucentis 0.5
Stage 1
Demarcation line
1 year f/u intermediate dAMD. Patient states new onset distortion x2 weeks OS. Subretinal fluid on OCT, leakage on angiogram. Treat with Eylea today and recheck in 4 weeks, sooner with changes. Continue AREDS/Amsler, closely monitor the right eye. What exam/modifier?
99214 [25]
Vabysmo
60
PEK
Punctate Epithelial Keratitis
No high cost meds
Medicaid
Stage 3
Neovascularized ridge
Work-in NP acute endophthalmitis 3 days s/p CEIOL. Urgent Ceftazadime and Vancomycin plus diagnostic A/C tap. Recheck tomorrow. May need vitrectomy in the future for persistent or worsening infection.
99205 [25]
N/C tap
Xipere
4 / 32
IIH
Idiopathic Intracranial Hypertension
2 approved diagnoses for Vabysmo
wAMD, DME
Zone 1
Measure the distance from the optic nerve to the fovea, then that distance again, then draw a circle as if you were using a protractor with the center point on the optic nerve
6 weeks s/p focal for DME OD. Proceed with IVA OU today as previously discussed and staged, patient agreed and tolerated treatment well. Recheck in 10 weeks, sooner with changes. What exam/modifiers?
post op exam [no 25 needed]
67028 [58] OD
67028 [79] OS